Working… Menu
Trial record 1 of 1 for:    ARV-110
Previous Study | Return to List | Next Study

Trial of ARV-110 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03888612
Recruitment Status : Recruiting
First Posted : March 25, 2019
Last Update Posted : June 25, 2021
Information provided by (Responsible Party):
Arvinas Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 31, 2022
Estimated Study Completion Date : April 30, 2023